Cost effectiveness of lowering cholesterol. Cost consequence analysis may be more useful to decision makers.
作者信息
Shepherd J
出版信息
BMJ. 1996 Nov 2;313(7065):1142; author reply 1144. doi: 10.1136/bmj.313.7065.1142.
Abstract
摘要
相似文献
1
Cost effectiveness of lowering cholesterol. Cost consequence analysis may be more useful to decision makers.
BMJ. 1996 Nov 2;313(7065):1142; author reply 1144. doi: 10.1136/bmj.313.7065.1142.
2
Cost effectiveness of lowering cholesterol. Study greatly underestimates the cost effectiveness of statin treatment.
BMJ. 1996 Nov 2;313(7065):1142; author reply 1144. doi: 10.1136/bmj.313.7065.1142a.
3
Cost effectiveness of lowering cholesterol. Full treatment of the costs and benefits is needed.
BMJ. 1996 Nov 2;313(7065):1143; author reply 1144. doi: 10.1136/bmj.313.7065.1143.
4
Cost effectiveness of lowering cholesterol. Study did not take account of confounders.
BMJ. 1996 Nov 2;313(7065):1142-3; author reply 1144. doi: 10.1136/bmj.313.7065.1142b.
5
Cost effectiveness of lowering cholesterol. Statin treatment should be started early.
BMJ. 1996 Nov 2;313(7065):1143; author reply 1144. doi: 10.1136/bmj.313.7065.1143a.
6
Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease.
JAMA. 2014 Feb 5;311(5):465-6. doi: 10.1001/jama.2014.110.
7
[Limitations of interventions against hypercholesterolemia].
Aten Primaria. 1996 Mar 15;17(4):305-6.
8
Cost effectiveness of lowering cholesterol. Costs in general practice.
BMJ. 1996 Nov 2;313(7065):1143-4. doi: 10.1136/bmj.313.7065.1143b.
9
Community Guide Cardiovascular Disease Economic Reviews: Tailoring Methods to Ensure Utility of Findings.
Am J Prev Med. 2017 Dec;53(6S2):S155-S163. doi: 10.1016/j.amepre.2017.06.012.
10
Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.
BMJ. 1996 Jun 8;312(7044):1443-8. doi: 10.1136/bmj.312.7044.1443.
引用本文的文献
1
A cost-consequences analysis of a primary care librarian question and answering service.
PLoS One. 2012;7(3):e33837. doi: 10.1371/journal.pone.0033837. Epub 2012 Mar 19.
2
[Are the Framingham tables directly applicable to the Mediterranean population?].
Aten Primaria. 2002 Jun 15;30(1):29-31. doi: 10.1016/s0212-6567(02)78960-9.
本文引用的文献
1
Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.
BMJ. 1996 Jun 8;312(7044):1443-8. doi: 10.1136/bmj.312.7044.1443.
2
Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study.
Int J Epidemiol. 1995 Feb;24(1):58-68. doi: 10.1093/ije/24.1.58.
3
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
N Engl J Med. 1995 Nov 16;333(20):1301-7. doi: 10.1056/NEJM199511163332001.
4
Measuring quality of life in patients with myocardial infarction or stroke: a feasibility study of four questionnaires in The Netherlands.
J Epidemiol Community Health. 1995 Oct;49(5):513-7. doi: 10.1136/jech.49.5.513.
Zotero 插件